Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment Strategies in Colorectal Cancer Patients With Initially Unresectable Liver-only Metastases CAIRO5 a Randomized Phase 3 Study of the Dutch Colorectal Cancer Group (DCCG)

NCT02162563 is registered in ClinicalTrials.gov with Dutch Colorectal Cancer Group as lead sponsor.

NCT NCT02162563
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02162563 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment Strategies in Colorectal Cancer Patients With Initially Unresectable Liver-only Metastases CAIRO5 a Randomized Phase 3 Study of the Dutch Colorectal Cancer Group (DCCG)
Lead sponsor
Dutch Colorectal Cancer Group
Phase
Phase 3
Overall status
Completed
Start date
July 31, 2014
Completion date
January 31, 2025
Enrollment
530 (actual)
Sites
56

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer, liver metastases